{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:31:15Z","timestamp":1788564675217,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ijantimicag.2020.106212","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T02:11:26Z","timestamp":1603505486000},"page":"106212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9379-4767","authenticated-orcid":false,"given":"Teodoro J.","family":"Oscanoa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen K.","family":"Kanters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Romero-Ortuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2020.106212_bib0001","article-title":"A global treatments for coronaviruses including COVID\u201019","author":"Yousefi","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0002","first-page":"1213","article-title":"Urgent guidance for navigating and circumventing the QTc-prolonging and torsadogenic potential of possible pharmacotherapies for coronavirus disease 19 (COVID-19)","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0003","first-page":"241","article-title":"Drug-induced QT interval prolongation: mechanisms and clinical management","volume":"3","author":"Nachimuthu","year":"2012","journal-title":"Ther Adv Drug Saf"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0004","first-page":"1639","article-title":"Predicting the unpredictable","volume":"67","author":"Schwartz","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0005","series-title":"Drug-induced long QT syndrome and Torsades de Pointes. Card","first-page":"185","author":"Woosley","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0006","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0007","series-title":"Clinical management of COVID-19: interim guidance","year":"2020"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0008","article-title":"Experience with hydroxychloroquine and azithromycin in the coronavirus disease 2019 pandemic: Implications for QT Interval monitoring","volume":"9","author":"Ramireddy","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0009","first-page":"1495","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0010","first-page":"d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0011","first-page":"177","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0012","first-page":"13","article-title":"Effect of Chloroquine, hydroxychloroquine, and azithromycin on the corrected QT interval in patients with SARS-CoV-2 infection","author":"Saleh","year":"2020","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0013","article-title":"Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-an observational study","author":"Ip","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0014","article-title":"Outcomes of hydroxychloroquine treatment among hospitalized COVID-19 patients in the United States-real-world evidence from a federated electronic medical record network","author":"Singh","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0015","article-title":"Enhanced ECG monitoring of COVID-19 patients","author":"Jain","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0016","article-title":"Characteristics and outcomes of hospitalized young adults with mild to moderate Covid-19 at a University Hospital in India","author":"Sharma","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0017","article-title":"Multicenter point-prevalence evaluation of the utilization and safety of drug therapies for COVID-19","author":"Rhodes","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0018","article-title":"Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend","author":"Hor","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0019","article-title":"Incidence and determinants of QT interval prolongation in COVID\u201019 patients treated with hydroxychloroquine and azithromycin","author":"Maraj","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0020","article-title":"Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir\/ritonavir in COVID\u201019","author":"Chong","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0021","article-title":"Association of hydroxychloroquine with QTc interval in patients with COVID-19","author":"Mazzanti","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0022","article-title":"A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications","author":"Oteo","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0023","article-title":"Assessment of QT Intervals in a case series of patients with coronavirus disease 2019 (COVID-19) Infection treated with hydroxychloroquine alone or in combination with azithromycin in an intensive care unit","author":"Bessi\u00e8re","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0024","article-title":"QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019","author":"Sridhar","year":"2020","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0025","article-title":"Acute QT Interval modifications during hydroxychloroquine-azithromycin treatment in the context of COVID-19 infection","author":"Voisin","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0026","article-title":"Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin","author":"Cipriani","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0027","first-page":"1800","article-title":"COVID-19 in solid organ transplant recipients: Initial report from the US epicenter","volume":"20","author":"Pereira","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0028","first-page":"1849","article-title":"COVID\u201019 in solid organ transplant recipients: A single\u2010center case series from Spain","volume":"20","author":"Fern\u00e1ndez\u2010Ruiz","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0029","article-title":"Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine\/azithromycin and other regimens in Marseille, France: A retrospective analysis","author":"Lagier","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0030","unstructured":"Mfeukeu-Kuate LM, Ngatchou W, Temgoua MN, Kouanfack C, Lemogoum D, Tochie J, et\u00a0al. Electrocardiographic safety of daily hydroxychloroquine 400mg plus azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon. medRxiv.https:\/\/doi.org\/10.1101\/2020.06.24.20139386 n.d."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0031","first-page":"m1849","article-title":"Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial","author":"Tang","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0032","article-title":"Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19)","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0033","article-title":"QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0034","article-title":"No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial","author":"Mahevas","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0035","first-page":"384","article-title":"No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection","volume":"50","author":"Molina","year":"2020","journal-title":"M\u00e9decine Mal Infect"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0036","article-title":"Towards optimization of hydroxychloroquine dosing in intensive care unit COVID-19 Patients","author":"Perinel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0037","first-page":"2493","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0038","first-page":"261","article-title":"Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series","volume":"98","author":"Louhaichi","year":"2020","journal-title":"Tunis Med"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0039","article-title":"QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review","author":"Jankelson","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0040","article-title":"Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis of confounder-adjusted 20212 hospitalized patients","author":"Kim","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0041","article-title":"The cardiac toxicity of chloroquine or hydroxychloroquine in COVID-19 Patients: A systematic review and meta-regression analysis","author":"Tleyjeh","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0042","article-title":"Chloroquine-induced QTc prolongation in COVID-19 patients","author":"van den Broek","year":"2020","journal-title":"Netherlands Hear J"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0043","article-title":"Effect of High vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0044","unstructured":"Isaksen JL, Holst AG, Pietersen A, Nielsen JB, Graff C, Kanters JK. Chloroquine, but not hydroxychlorquine, prolongs the QT interval in a primary care population. medRxiv 2020.06.19.20135475; doi: https:\/\/doi.org\/10.1101\/2020.06.19.20135475 n.d. https:\/\/doi.org\/10.1101\/2020.06.19.20135475."},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0045","first-page":"U666","article-title":"PA. A case of QT-interval prolongation precipitated by azithromycin","volume":"116","author":"Matsunaga","year":"2003","journal-title":"N Z Med J"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0046","first-page":"1572","article-title":"QT Prolongation associated with azithromycin\/amiodarone combination","volume":"24","author":"Samarendra","year":"2001","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0047","first-page":"30","article-title":"Azithromycin-induced QT prolongation in elderly patient","volume":"77","author":"Russo","year":"2006","journal-title":"Acta Biomed"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0048","first-page":"1579","article-title":"Azithromycin-induced Torsade de Pointes","volume":"30","author":"Huang","year":"2007","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0049","first-page":"1221","article-title":"Polymorphic ventricular tachycardia with a normal QT interval following azithromycin","volume":"28","author":"Kim","year":"2005","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0050","first-page":"10","article-title":"Azithromycin causes a novel proarrhythmic syndrome","author":"Yang","year":"2017","journal-title":"Circ Arrhythmia Electrophysiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0051","first-page":"1881","article-title":"Azithromycin and the risk of cardiovascular death","volume":"366","author":"Ray","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0052","series-title":"The cardiotoxicity of antimalarials","year":"2016"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0053","first-page":"289","article-title":"Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base","volume":"8","author":"Bouchaud","year":"2009","journal-title":"Malar J"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0054","first-page":"1541","article-title":"Prolonged QT interval with halofantrine","volume":"342","author":"Monlun","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0055","first-page":"549","article-title":"Cardiotoxicity of antimalarial drugs","volume":"7","author":"White","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0056","series-title":"In ACR\/ARHP Annual Meeting","article-title":"Long QT and hydroxychloroquine; a poorly recognised problem in rheumatology patients","author":"Negoescu","year":"2013"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0057","first-page":"919","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: A systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0058","first-page":"545","article-title":"Electrocardiogram abnormalities related to anti-malarials in systemic lupus erythematosus","volume":"36","author":"McGhie","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0059","article-title":"Effects of hydroxychloroquine treatment on QT interval","author":"Hooks","year":"2020","journal-title":"Hear Rhythm"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0060","first-page":"101","article-title":"Epidemiology of symptomatic drug-induced long QT syndrome and torsade de pointes in Germany","volume":"16","author":"Sarganas","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0061","first-page":"2459","article-title":"Predicting drug-induced QT prolongation and torsades de pointes","volume":"594","author":"Roden","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0062","first-page":"5","article-title":"Long QT Syndrome and Sinus Bradycardia\u2013A","author":"Wilders","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0063","first-page":"660","article-title":"High prevalence of the risk factors for QT interval prolongation and associated drug\u2013drug interactions in coronary care units","volume":"130","author":"Khan","year":"2018","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ijantimicag.2020.106212_bib0064","unstructured":"National Medicines. Information Centre. ST. JAMES'S HOSPITAL D. DRUG-INDUCED QT INTERVAL PROLONGATION. Vol. 21. NUMBER 6. 2015. www.nmic.ie . http:\/\/www.stjames.ie\/GPsHealthcareProfessionals\/Newsletters\/NMICBulletins\/NMICBulletins2015\/NMIC%20Bulletin%20February%202016%20-%20Drug-Induced%20QT%20Interval%20Prolongation% n.d."}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920304234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857920304234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:40:03Z","timestamp":1760377203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857920304234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0924857920304234"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106212","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency of Long QT in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.106212","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106212"}}